To all interested List Members.
                        Recently, we have experienced encouraging
results with experimental volunteers who were on a standard Cetyl
Myristoleate (CMO) protocol..  These volunteers are, all, affected by
Systemic Lupus Erythrematosus (SLE).  We believe the improvement to be
the result of the CMO nullifying the "scavenger effect", which appears
to be so devastating in many cases of progressive osteo/rheumatoid
arthritis.  Presently, our data is quite limited----but rather
dramatic---and deemed to be sufficiently important to be mentioned to
list membership.
                                Sincerely.  Brooks Bradley.
p.s.  Please do not inquire as to protocol particulars.  We DO NOT
prescribe or practice any form of medicine, being an experimental
research group ONLY.
        I believe people of nominal intelligence can design standard
modifications of known protocols, utilizing CMO, in a manner sufficient
to evaluate possible efficacy.



--
The silver-list is a moderated forum for discussion of colloidal silver.

To join or quit silver-list or silver-digest send an e-mail message to: 
[email protected]  -or-  [email protected]
with the word subscribe or unsubscribe in the SUBJECT line.

To post, address your message to: [email protected]

List maintainer: Mike Devour <[email protected]>